Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,500
Closed -$3.69M 929
2022
Q3
$3.69M Buy
27,500
+7,500
+38% +$1.08M 0.17% 129
2022
Q2
$3.06M Sell
20,000
-16,500
-45% -$2.52M 0.12% 193
2022
Q1
$5.92M Buy
+36,500
New +$5.3M 0.21% 87
2021
Q2
Sell
-30,000
Closed -$3.25M 1059
2021
Q1
$3.25M Buy
+30,000
New +$3.21M 0.13% 145
2016
Q1
Sell
-8,300
Closed -$492K 662
2015
Q4
$492K Hold
8,300
0.03% 358
2015
Q3
$452K Sell
8,300
-38,180
-82% -$2.49M 0.03% 410
2015
Q2
$3.12M Buy
+46,480
New +$3.03M 0.15% 142

Other funds holding ABBV

CSS LLC's ABBV Position: Q1 2025 in Review

CSS LLC sold out of AbbVie (ABBV) in Q1 2025, closing a stake of 3,340 shares — an estimated $594K sold.

CSS LLC first reported a position in ABBV in Q4 2013 and held it in 30 quarters. The position peaked at $2.56M in Q2 2018. 3,826 funds tracked by Wall St. Rank hold ABBV as of Q1 2025.

  • CSS LLC reported no remaining AbbVie position as of Q1 2025 after selling out during the quarter.
  • CSS LLC sold 3,340 AbbVie shares in Q1 2025, an estimated $594K.
  • CSS LLC first reported a position in AbbVie in Q4 2013 and held it in 30 quarters.
  • CSS LLC's AbbVie position peaked at $2.56M in Q2 2018.
  • 3,826 funds tracked by Wall St. Rank held AbbVie as of Q1 2025.

Based on CSS LLC's 13F filing for Q1 2025, filed 15 May 2025.